OpenVSafe by OpenVAERS
Search V-safe

5SC-11180-12275

5 vaccinations 16 coded responses 59 check-ins 15 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
980 / WA
Registered
2021-03-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-11
    Registered in v-safe
  2. 2021-03-11
    Dose 1 — Moderna
  3. 2021-03-11
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-03-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-03-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-18
    Survey response — day 7, dose 1
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Probably unrelated hand pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-25
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-04-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-08
    Dose 2 — Moderna
  14. 2021-04-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-29
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-05-06
    Survey response — day 28, dose 2
    MedDRA: Rash, Rash erythematous, Rash pruritic — Feeling: Good
    Free text: Rash on left side of my back. Red bumps that itched. This may have been from Shingrix booster immunization on 4/26/2021 (>2 weeks after 2nd Covid immunization-4/8/2021).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-20
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-07-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-10-07
    Survey response — 6 months, dose 2
    MedDRA: Chromaturia, Headache, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Some intermittent low grade fevers/headaches and some dark (brown) urine. Both seemed to have resolved mostly.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-10-07
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  23. 2021-10-12
    Call successful
    Participant prefers to complete VAERS report online
  24. 2021-11-02
    Dose 3 — Moderna
  25. 2021-11-02
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  26. 2021-11-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  27. 2021-11-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  28. 2021-11-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oral mucosal blistering — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site
    Free text: Blisters on roof of mouth
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Rash, not including the immediate area around the injection site
    Adult check-in
  30. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  31. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  32. 2021-11-09
    Survey response — day 7, dose 3
    MedDRA: Rash, Rash erythematous — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Lacy red rash on abdomen
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-16
    Survey response — day 14, dose 3
    MedDRA: Asthma, Condition aggravated, Pre-existing disease — Feeling: Fair
    Free text: Increase in allergy/asthma type symptoms
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-23
    Survey response — day 21, dose 3
    MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Good
    Free text: Mild symptoms of allergy:asthma worsening only slightly.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-11-30
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  36. 2021-12-07
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  37. 2021-12-14
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  38. 2022-02-01
    Survey response — 3 months, dose 3
    MedDRA: Sinus headache — Feeling: Good
    Free text: Sinus head aches
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-05-03
    Survey response — 6 months, dose 3
    MedDRA: Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Asthma symptoms (due to seasonal allergies?)
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-05-16
    Dose 4 — Moderna
  41. 2022-05-16
    Health check-in — day 0, dose 4
    Feeling: Fair · None
    Adult check-in
  42. 2022-05-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  43. 2022-05-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  44. 2022-05-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  45. 2022-05-20
    Survey response — days 1–6 daily, dose 4
    MedDRA: Body temperature increased — Feeling: Fair · Site: Pain · Chills, Headache · Be unable to do your normal daily activities
    Free text: Low grade fever last night as high as 99.6
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  47. 2022-05-23
    Health check-in — day 7, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  48. 2022-05-30
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  49. 2022-06-08
    Survey response — day 21, dose 4
    MedDRA: Asthma — Feeling: Fair
    Free text: Worsened asthma symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-06-13
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  51. 2022-06-20
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  52. 2022-06-27
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-08-16
    Survey response — 3 months, dose 4
    MedDRA: Endoscopy abnormal, Gastrooesophageal reflux disease, Oesophageal disorder, Oesophageal irritation, Oesophageal mucosa erythema, Oesophagitis, Pharyngeal swelling, Pre-existing disease, Throat irritation — Feeling: Fair · Be unable to do your normal daily activities
    Free text: I have had slowly increasing symptoms of GERD for the last year to a year and a half. A recent upper endoscopy showed erythema and furrowing in lower 2/3 of esophagus. Biopsy results still pending. Irritation/swelling present in throat/esophagus now
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-09-26
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  55. 2022-09-27
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  56. 2022-09-28
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  57. 2022-09-30
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  58. 2022-10-01
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  59. 2022-10-02
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  60. 2022-10-03
    Health check-in — day 7, dose 5
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  61. 2022-10-10
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  62. 2022-10-18
    Health check-in — day 21, dose 5
    Feeling: Fair
    Adult check-in
  63. 2022-10-24
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  64. 2022-10-31
    Survey response — day 35, dose 5
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  65. 2022-11-09
    Survey response — day 42, dose 5
    MedDRA: Sinus headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sinus headache
    MedDRA releases: 2024-11 · check-in free text available
  66. 2022-12-26
    Survey response — 3 months, dose 5
    MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities
    Free text: Covid 19 infection
    MedDRA releases: 2024-11 · check-in free text available
  67. 2023-03-28
    Survey response — 6 months, dose 5
    MedDRA: Adverse reaction, COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-11Moderna
22021-04-08Moderna
32021-11-02Moderna No
42022-05-16Moderna No
52022-09-26Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — day 7, dose 1

2021-03-18

Systemic reaction (other): Probably unrelated hand pain.

Release 8 — day 28, dose 2

2021-05-06

Symptoms: Rash on left side of my back. Red bumps that itched. This may have been from Shingrix booster immunization on 4/26/2021 (>2 weeks after 2nd Covid immunization-4/8/2021).

Release 10 — 6 months, dose 2

2021-10-07

Symptoms: Some intermittent low grade fevers/headaches and some dark (brown) urine. Both seemed to have resolved mostly.

Release 10 — days 1–6 daily, dose 3

2021-11-05

Systemic reaction (other): Blisters on roof of mouth

Release 10 — day 7, dose 3

2021-11-09

Systemic reaction (other): Lacy red rash on abdomen

Release 10 — day 14, dose 3

2021-11-16

Symptoms: Increase in allergy/asthma type symptoms

Release 10 — day 21, dose 3

2021-11-23

Symptoms: Mild symptoms of allergy:asthma worsening only slightly.

Release 11 — 3 months, dose 3

2022-02-01

Symptoms: Sinus head aches

Release 11 — 6 months, dose 3

2022-05-03

Symptoms: Asthma symptoms (due to seasonal allergies?)

Release 11 — days 1–6 daily, dose 4

2022-05-20

Systemic reaction (other): Low grade fever last night as high as 99.6

Release 11 — day 21, dose 4

2022-06-08

Symptoms: Worsened asthma symptoms.

Release 12 — 3 months, dose 4

2022-08-16

Symptoms: I have had slowly increasing symptoms of GERD for the last year to a year and a half. A recent upper endoscopy showed erythema and furrowing in lower 2/3 of esophagus. Biopsy results still pending. Irritation/swelling present in throat/esophagus now cut off by CDC

Release 12 — day 35, dose 5

2022-10-31

Symptoms: Fatigue

Release 12 — day 42, dose 5

2022-11-09

Symptoms: Sinus headache

Release 12 — 3 months, dose 5

2022-12-26

Symptoms: Covid 19 infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse reaction · · ✓
SDAsthma · · ✓
SDChromaturia · · ✓
SDCondition aggravated · · ✓
SDCOVID-19 · · ✓
SDEndoscopy abnormal · · ✓
SDFatigue · · ✓
SDGastrooesophageal reflux disease · · ✓
SDHeadache · · ✓
SDHypersensitivity · · ✓
SDOesophageal disorder · · ✓
SDOesophageal irritation · · ✓
SDOesophageal mucosa erythema · · ✓
SDOesophagitis · · ✓
SDPharyngeal swelling · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRash ✓ ✓ ✓
SDRash erythematous ✓ ✓ ✓
SDRash pruritic ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus headache · · ✓
SDThroat irritation · · ✓
SROBody temperature increased · · ✓
SROOral mucosal blistering · · ✓
SRORash · · ✓
SRORash erythematous · · ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release